Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, is seeking an experienced Senior Advisor, Study Operations - Nonclinical Toxicology. Centessa is a clinical-stage company developing orexin receptor 2 (OX2R) agonists, including cleminorexton, for narcolepsy and potentially other sleep-wake disorders, with additional clinical and preclinical-stage assets for neurological, neurodegenerative, and neuropsychiatric conditions. The role manages and oversees day-to-day operations for toxicology and safety pharmacology studies conducted at selected CROs. Responsibilities span study forecasting, budgeting, planning, data management, quality assurance, compliance, communications, and collaboration with functional teams across the orexin agonist portfolio. The position supports expansion of translational science and nonclinical development capabilities and calls for accuracy, attention to detail, and the ability to identify and resolve issues during studies.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior